Stegostoma fasciatum isolate 6-17 chromosome 19, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039245.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
short transient receptor potential channel 4-associated protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 6
uncharacterized LOC125461362, transcript variant X3
uncharacterized LOC125461362, transcript variant X2
uncharacterized LOC125461362, transcript variant X1
uncharacterized LOC125461362, transcript variant X6
uncharacterized LOC125461362, transcript variant X5
uncharacterized protein LOC125461362 isoform X1
uncharacterized protein LOC125461362 isoform X3
uncharacterized LOC125461362, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC125461362 isoform X2
oxidative stress induced growth inhibitor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X4
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X3
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like
cytochrome c1, heme protein, mitochondrial
endoplasmic reticulum-Golgi intermediate compartment protein 3
myelocytomatosis oncogene homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
myelocytomatosis oncogene homolog isoform X1
myelocytomatosis oncogene homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
myelocytomatosis oncogene homolog isoform X2
myelocytomatosis oncogene homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
myelocytomatosis oncogene homolog isoform X3
retinoblastoma-like 1 (p107), transcript variant X2
retinoblastoma-like 1 (p107), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
retinoblastoma-like protein 1 isoform X2
retinoblastoma-like protein 1 isoform X1
chromodomain helicase DNA binding protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
chromodomain-helicase-DNA-binding protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X5
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X4
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X2
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X8
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X7
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X1
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X3
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X10
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X9
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X6
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X12
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X11
ral GTPase-activating protein subunit beta isoform X8
ral GTPase-activating protein subunit beta isoform X7
ral GTPase-activating protein subunit beta isoform X6
ral GTPase-activating protein subunit beta isoform X5
ral GTPase-activating protein subunit beta isoform X4
ral GTPase-activating protein subunit beta isoform X2
ral GTPase-activating protein subunit beta isoform X3
ral GTPase-activating protein subunit beta isoform X1
TOX high mobility group box family member 2, transcript variant X1
TOX high mobility group box family member 2, transcript variant X2
TOX high mobility group box family member 2, transcript variant X6
TOX high mobility group box family member 2, transcript variant X7
TOX high mobility group box family member 2 isoform X1
TOX high mobility group box family member 2 isoform X2
TOX high mobility group box family member 2 isoform X5
TOX high mobility group box family member 2 isoform X6
TOX high mobility group box family member 2, transcript variant X4
TOX high mobility group box family member 2, transcript variant X3
TOX high mobility group box family member 2 isoform X3
TOX high mobility group box family member 2, transcript variant X5
TOX high mobility group box family member 2 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
RNA binding motif protein 12, transcript variant X1
RNA binding motif protein 12, transcript variant X2
RNA binding motif protein 12, transcript variant X4
RNA binding motif protein 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DENN domain-containing protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DENN domain-containing protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
neuronal acetylcholine receptor subunit alpha-4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 111 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium channel subfamily K member 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
regulating synaptic membrane exocytosis protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
14-3-3 protein beta/alpha-1-like, transcript variant X2
14-3-3 protein beta/alpha-1-like, transcript variant X5
14-3-3 protein beta/alpha-1-like, transcript variant X3
14-3-3 protein beta/alpha-1-like, transcript variant X6
14-3-3 protein beta/alpha-1-like, transcript variant X4
14-3-3 protein beta/alpha-1-like, transcript variant X1
14-3-3 protein beta/alpha-1-like isoform X1
14-3-3 protein beta/alpha-1-like isoform X2
embryonic polyadenylate-binding protein A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
translocase of outer mitochondrial membrane 34
mitochondrial import receptor subunit TOM34
opioid growth factor receptor-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
death-inducer obliterator 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
death-inducer obliterator 1-like, transcript variant X2
death-inducer obliterator 1-like isoform X1
death-inducer obliterator 1-like isoform X2
protein O-glucosyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein O-glucosyltransferase 1, transcript variant X3
protein O-glucosyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein O-glucosyltransferase 1 isoform X2
protein O-glucosyltransferase 1 isoform X3
protein O-glucosyltransferase 1 isoform X1
translocase of inner mitochondrial membrane domain containing 1
complex I assembly factor TIMMDC1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
proteasome inhibitor subunit 1, transcript variant X2
proteasome inhibitor subunit 1, transcript variant X1
proteasome inhibitor PI31 subunit isoform X1
proteasome inhibitor PI31 subunit isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
double-strand-break repair protein rad21 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP1A-like
agouti signaling protein 1, transcript variant X2
agouti signaling protein 1, transcript variant X6
agouti signaling protein 1, transcript variant X5
agouti signaling protein 1, transcript variant X1
agouti signaling protein 1, transcript variant X4
agouti signaling protein 1, transcript variant X3
eukaryotic translation initiation factor 2, subunit 2 beta
eukaryotic translation initiation factor 2 subunit 2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X5
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X3
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X4
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X1
zinc finger protein 341, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger protein 341, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X1
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X3
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X4
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X2
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X1
family with sequence similarity 83 member C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X1
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X2
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X2
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
oxidative stress responsive serine-rich 1, transcript variant X4
oxidative stress responsive serine-rich 1, transcript variant X2
oxidative stress responsive serine-rich 1, transcript variant X3
oxidative stress responsive serine-rich 1, transcript variant X1
oxidative stress-responsive serine-rich protein 1
recombination signal binding protein for immunoglobulin kappa J region-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
recombination signal binding protein for immunoglobulin kappa J region-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
recombination signal binding protein for immunoglobulin kappa J region-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
recombining binding protein suppressor of hairless-like protein isoform X2
recombining binding protein suppressor of hairless-like protein isoform X3
recombining binding protein suppressor of hairless-like protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
potassium voltage-gated channel subfamily S member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase 3/4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase 3/4, transcript variant X1
uncharacterized protein LOC562650 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized protein LOC562650 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC562650 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC562650 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC562650 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial
RNA binding motif protein 39a, transcript variant X1
RNA binding motif protein 39a, transcript variant X6
RNA binding motif protein 39a, transcript variant X4
RNA binding motif protein 39a, transcript variant X5
RNA binding motif protein 39a, transcript variant X3
RNA binding motif protein 39a, transcript variant X2
GTP-binding protein GEM-like, transcript variant X3
GTP-binding protein GEM-like, transcript variant X5
GTP-binding protein GEM-like, transcript variant X6
GTP-binding protein GEM-like, transcript variant X2
GTP-binding protein GEM-like, transcript variant X7
GTP-binding protein GEM-like, transcript variant X1
GTP-binding protein GEM-like, transcript variant X4
uncharacterized protein C20orf96 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tribbles pseudokinase 3, transcript variant X3
tribbles pseudokinase 3, transcript variant X1
tribbles pseudokinase 3, transcript variant X4
tribbles pseudokinase 3, transcript variant X2
ranBP-type and C3HC4-type zinc finger-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ranBP-type and C3HC4-type zinc finger-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ranBP-type and C3HC4-type zinc finger-containing protein 1-like isoform X1
ranBP-type and C3HC4-type zinc finger-containing protein 1-like isoform X2
TBC1 domain family, member 20, transcript variant X3
TBC1 domain family, member 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
TBC1 domain family, member 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TBC1 domain family, member 20, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
casein kinase II subunit alpha, transcript variant X4
casein kinase II subunit alpha, transcript variant X5
casein kinase II subunit alpha, transcript variant X6
casein kinase II subunit alpha, transcript variant X2
casein kinase II subunit alpha, transcript variant X3
casein kinase II subunit alpha, transcript variant X8
casein kinase II subunit alpha, transcript variant X1
casein kinase II subunit alpha, transcript variant X7
casein kinase II subunit alpha isoform X4
casein kinase II subunit alpha isoform X3
casein kinase II subunit alpha isoform X2
casein kinase II subunit alpha isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transcriptional repressor scratch 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 52 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 52 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 52 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 52, riboflavin transporter, member 3-A
SAM domain and HD domain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SAM domain and HD domain 1, transcript variant X1
deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X1
deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
E3 ubiquitin-protein ligase Itchy-like, transcript variant X3
E3 ubiquitin-protein ligase Itchy-like, transcript variant X1
E3 ubiquitin-protein ligase Itchy-like, transcript variant X5
E3 ubiquitin-protein ligase Itchy-like, transcript variant X4
E3 ubiquitin-protein ligase Itchy-like, transcript variant X2
E3 ubiquitin-protein ligase Itchy-like, transcript variant X6
E3 ubiquitin-protein ligase Itchy-like isoform X1
E3 ubiquitin-protein ligase Itchy-like, transcript variant X7
E3 ubiquitin-protein ligase Itchy-like isoform X2
dynein light chain roadblock-type 2-like, transcript variant X2
dynein light chain roadblock-type 2-like isoform X2
dynein light chain roadblock-type 2-like, transcript variant X1
dynein light chain roadblock-type 2-like isoform X1
protein CBFA2T2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein CBFA2T2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein CBFA2T2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein CBFA2T2-like, transcript variant X4
protein CBFA2T2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein CBFA2T2-like, transcript variant X2
protein CBFA2T2-like, transcript variant X6
protein CBFA2T2-like, transcript variant X7
N-terminal EF-hand calcium-binding protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-terminal EF-hand calcium-binding protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
N-terminal EF-hand calcium-binding protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
histocompatibility (minor) 13, transcript variant X2
histocompatibility (minor) 13, transcript variant X1
minor histocompatibility antigen H13 isoform X2
minor histocompatibility antigen H13 isoform X1
Rho GTPase activating protein 46b, transcript variant X1
rho GTPase-activating protein 39 isoform X1
Rho GTPase activating protein 46b, transcript variant X3
rho GTPase-activating protein 39 isoform X3
Rho GTPase activating protein 46b, transcript variant X2
rho GTPase-activating protein 39 isoform X2
PHD finger protein 20-like, transcript variant X1
PHD finger protein 20-like, transcript variant X4
PHD finger protein 20-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PHD finger protein 20-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein NDRG3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein NDRG3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ER degradation enhancer, mannosidase alpha-like 2, transcript variant X1
ER degradation-enhancing alpha-mannosidase-like protein 2 isoform X1
ER degradation enhancer, mannosidase alpha-like 2, transcript variant X2
ER degradation-enhancing alpha-mannosidase-like protein 2 isoform X2
microtubule-associated proteins 1A/1B light chain 3A
phosphatidylinositol glycan anchor biosynthesis, class U
phosphatidylinositol glycan anchor biosynthesis class U protein
uncharacterized LOC125461606, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125461606, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 1 isoform X1
tumor protein p53-inducible nuclear protein 2 isoform X2
nuclear receptor coactivator 6, transcript variant X5
nuclear receptor coactivator 6, transcript variant X6
nuclear receptor coactivator 6, transcript variant X4
nuclear receptor coactivator 6, transcript variant X1
nuclear receptor coactivator 6, transcript variant X2
nuclear receptor coactivator 6, transcript variant X3
nuclear receptor coactivator 6 isoform X3
nuclear receptor coactivator 6 isoform X4
nuclear receptor coactivator 6 isoform X2
nuclear receptor coactivator 6 isoform X1
cylindromatosis (turban tumor syndrome), b, transcript variant X3
cylindromatosis (turban tumor syndrome), b, transcript variant X2
cylindromatosis (turban tumor syndrome), b, transcript variant X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
osteoclast stimulatory transmembrane protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 13 member 3, transcript variant X2
solute carrier family 13 member 3, transcript variant X1
solute carrier family 13 member 3 isoform X2
solute carrier family 13 member 3 isoform X1
protein phosphatase 1 regulatory inhibitor subunit 16B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
family with sequence similarity 83 member D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable ATP-dependent RNA helicase DHX35, transcript variant X1
probable ATP-dependent RNA helicase DHX35 isoform X1
probable ATP-dependent RNA helicase DHX35, transcript variant X2
probable ATP-dependent RNA helicase DHX35 isoform X2
zinc fingers and homeoboxes protein 3-like, transcript variant X3
zinc fingers and homeoboxes protein 3-like, transcript variant X1
zinc fingers and homeoboxes protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc fingers and homeoboxes protein 3-like isoform X2
zinc fingers and homeoboxes protein 3-like isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00568
transcription factor MafB-like, transcript variant X1
transcription factor MafB-like, transcript variant X2
nuclear receptor coactivator 3-like, transcript variant X10
nuclear receptor coactivator 3-like, transcript variant X1
nuclear receptor coactivator 3-like, transcript variant X2
nuclear receptor coactivator 3-like, transcript variant X3
nuclear receptor coactivator 3-like, transcript variant X4
nuclear receptor coactivator 3-like, transcript variant X5
nuclear receptor coactivator 3-like, transcript variant X6
nuclear receptor coactivator 3-like, transcript variant X8
nuclear receptor coactivator 3-like, transcript variant X7
nuclear receptor coactivator 3-like, transcript variant X9
nuclear receptor coactivator 3-like isoform X2
nuclear receptor coactivator 3-like isoform X1
translocating chain-associated membrane protein 1-like 1, transcript variant X2
translocating chain-associated membrane protein 1-like 1, transcript variant X1
translocating chain-associated membrane protein 1-like 1, transcript variant X3
translocating chain-associated membrane protein 1-like 1 isoform X1
translocating chain-associated membrane protein 1-like 1 isoform X2
zinc finger, MYND-type containing 8, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X8
zinc finger, MYND-type containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein kinase C-binding protein 1 isoform X3
zinc finger, MYND-type containing 8, transcript variant X10
zinc finger, MYND-type containing 8, transcript variant X14
protein kinase C-binding protein 1 isoform X11
zinc finger, MYND-type containing 8, transcript variant X1
zinc finger, MYND-type containing 8, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X2
zinc finger, MYND-type containing 8, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X12
zinc finger, MYND-type containing 8, transcript variant X4
protein kinase C-binding protein 1 isoform X1
protein kinase C-binding protein 1 isoform X8
protein kinase C-binding protein 1 isoform X2
protein kinase C-binding protein 1 isoform X5
protein kinase C-binding protein 1 isoform X6
protein kinase C-binding protein 1 isoform X10
protein kinase C-binding protein 1 isoform X9
protein kinase C-binding protein 1 isoform X4
zinc finger, MYND-type containing 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein kinase C-binding protein 1 isoform X7
eyes absent homolog 1-like, transcript variant X2
eyes absent homolog 1-like, transcript variant X4
eyes absent homolog 1-like, transcript variant X7
eyes absent homolog 1-like, transcript variant X1
eyes absent homolog 1-like, transcript variant X8
eyes absent homolog 1-like, transcript variant X3
eyes absent homolog 1-like, transcript variant X5
eyes absent homolog 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 2 member 10, transcript variant X5
solute carrier family 2 member 10, transcript variant X4
solute carrier family 2 member 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 2 member 10, transcript variant X2
solute carrier family 2 member 10, transcript variant X3
solute carrier family 2, facilitated glucose transporter member 10
serum/glucocorticoid regulated kinase 2a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serum/glucocorticoid regulated kinase 2a, transcript variant X5
serum/glucocorticoid regulated kinase 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serum/glucocorticoid regulated kinase 2a, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase Sgk2 isoform X1
serine/threonine-protein kinase Sgk2 isoform X6
serum/glucocorticoid regulated kinase 2a, transcript variant X2
serum/glucocorticoid regulated kinase 2a, transcript variant X4
serum/glucocorticoid regulated kinase 2a, transcript variant X3
serum/glucocorticoid regulated kinase 2a, transcript variant X6
serine/threonine-protein kinase Sgk2 isoform X2
serine/threonine-protein kinase Sgk2 isoform X4
serine/threonine-protein kinase Sgk2 isoform X3
serine/threonine-protein kinase Sgk2 isoform X5
intraflagellar transport 52 homolog (Chlamydomonas)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
intraflagellar transport protein 52 homolog
v-myb avian myeloblastosis viral oncogene homolog-like 2b, transcript variant X1
v-myb avian myeloblastosis viral oncogene homolog-like 2b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
v-myb avian myeloblastosis viral oncogene homolog-like 2b, transcript variant X3
v-myb avian myeloblastosis viral oncogene homolog-like 2b, transcript variant X2
v-myb avian myeloblastosis viral oncogene homolog-like 2b isoform X1
v-myb avian myeloblastosis viral oncogene homolog-like 2b isoform X3
v-myb avian myeloblastosis viral oncogene homolog-like 2b isoform X2
TAF4A RNA polymerase II, TATA box binding protein (TBP)-associated factor
transcription initiation factor TFIID subunit 4
LSM family member 14B, transcript variant X1
LSM family member 14B, transcript variant X2
LSM family member 14B, transcript variant X3
LSM family member 14B, transcript variant X4
calcium-responsive transactivator-like, transcript variant X2
calcium-responsive transactivator-like, transcript variant X1
calcium-responsive transactivator-like, transcript variant X4
calcium-responsive transactivator-like isoform X1
calcium-responsive transactivator-like isoform X2
calcium-responsive transactivator-like isoform X4
calcium-responsive transactivator-like, transcript variant X3
calcium-responsive transactivator-like isoform X3
mitochondrial ribosome-associated GTPase 2
uncharacterized protein SCO4629-like, transcript variant X6
uncharacterized protein SCO4629-like, transcript variant X1
uncharacterized protein SCO4629-like, transcript variant X2
uncharacterized protein SCO4629-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein SCO4629-like, transcript variant X4
uncharacterized protein SCO4629-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
oxysterol binding protein-like 2b, transcript variant X6
oxysterol binding protein-like 2b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
oxysterol binding protein-like 2b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
oxysterol binding protein-like 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
oxysterol binding protein-like 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
oxysterol binding protein-like 2b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
oxysterol-binding protein-related protein 2b
ADRM1 26S proteasome ubiquitin receptor, transcript variant X2
ADRM1 26S proteasome ubiquitin receptor, transcript variant X1
proteasomal ubiquitin receptor ADRM1 isoform X1
proteasomal ubiquitin receptor ADRM1 isoform X2
ribosomal protein S21, transcript variant X1
ribosomal protein S21, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC125461430, transcript variant X3
uncharacterized LOC125461430, transcript variant X2
uncharacterized LOC125461430, transcript variant X1
uncharacterized protein LOC125461430 isoform X3
uncharacterized protein LOC125461430 isoform X2
uncharacterized protein LOC125461430 isoform X1
GATA binding protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GATA binding protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
GATA binding protein 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier organic anion transporter family, member 4A1, transcript variant X1
solute carrier organic anion transporter family, member 4A1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier organic anion transporter family member 4A1 isoform X1
solute carrier organic anion transporter family member 4A1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Src-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Src-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 122 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Src-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Src-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Src-like isoform X3
proto-oncogene tyrosine-protein kinase Src-like isoform X2
proto-oncogene tyrosine-protein kinase Src-like isoform X1
mannosidase beta like, transcript variant X2
mannosidase beta like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2
phosphatidate phosphatase LPIN2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phosphatidate phosphatase LPIN2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
phosphatidate phosphatase LPIN2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphatidate phosphatase LPIN2-like isoform X1
phosphatidate phosphatase LPIN2-like isoform X2
homeobox protein TGIF2-like, transcript variant X3
homeobox protein TGIF2-like, transcript variant X2
homeobox protein TGIF2-like, transcript variant X1
disks large-associated protein 4-like, transcript variant X5
disks large-associated protein 4-like, transcript variant X4
disks large-associated protein 4-like, transcript variant X2
disks large-associated protein 4-like, transcript variant X6
disks large-associated protein 4-like, transcript variant X1
disks large-associated protein 4-like, transcript variant X3
disks large-associated protein 4-like, transcript variant X8
disks large-associated protein 4-like, transcript variant X7
disks large-associated protein 4-like isoform X2
disks large-associated protein 4-like isoform X1
disks large-associated protein 4-like isoform X4
disks large-associated protein 4-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
band 4.1-like protein 1, transcript variant X7
band 4.1-like protein 1, transcript variant X9
band 4.1-like protein 1, transcript variant X6
band 4.1-like protein 1, transcript variant X12
band 4.1-like protein 1, transcript variant X11
band 4.1-like protein 1, transcript variant X1
band 4.1-like protein 1, transcript variant X8
band 4.1-like protein 1, transcript variant X10
band 4.1-like protein 1, transcript variant X13
band 4.1-like protein 1, transcript variant X14
band 4.1-like protein 1, transcript variant X4
band 4.1-like protein 1, transcript variant X3
band 4.1-like protein 1, transcript variant X5
band 4.1-like protein 1, transcript variant X2
serine/arginine-rich splicing factor 6-like, transcript variant X1
serine/arginine-rich splicing factor 6-like isoform X1
serine/arginine-rich splicing factor 6-like, transcript variant X2
serine/arginine-rich splicing factor 6-like isoform X2
L3MBTL histone methyl-lysine binding protein 1, transcript variant X1
L3MBTL histone methyl-lysine binding protein 1, transcript variant X5
L3MBTL histone methyl-lysine binding protein 1, transcript variant X2
L3MBTL histone methyl-lysine binding protein 1, transcript variant X3
L3MBTL histone methyl-lysine binding protein 1, transcript variant X4
L3MBTL histone methyl-lysine binding protein 1, transcript variant X6
lethal(3)malignant brain tumor-like protein 1 isoform X1
lethal(3)malignant brain tumor-like protein 1 isoform X2
lethal(3)malignant brain tumor-like protein 1 isoform X3
rho GTPase-activating protein 18-like, transcript variant X7
rho GTPase-activating protein 18-like, transcript variant X5
rho GTPase-activating protein 18-like, transcript variant X6
rho GTPase-activating protein 18-like, transcript variant X1
rho GTPase-activating protein 18-like, transcript variant X2
rho GTPase-activating protein 18-like, transcript variant X3
rho GTPase-activating protein 18-like, transcript variant X4
rho GTPase-activating protein 18-like isoform X1
rho GTPase-activating protein 40-like isoform X2
rho GTPase-activating protein 40-like isoform X3
rho GTPase-activating protein 18-like isoform X4
rho GTPase-activating protein 18-like isoform X5
solute carrier family 32 member 1, transcript variant X2
solute carrier family 32 member 1, transcript variant X1
solute carrier family 32 member 1, transcript variant X3
vesicular inhibitory amino acid transporter
protein tyrosine phosphatase receptor type T, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein tyrosine phosphatase receptor type T, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase receptor type T, transcript variant X3
protein tyrosine phosphatase receptor type T, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein tyrosine phosphatase receptor type T, transcript variant X6
protein tyrosine phosphatase receptor type T, transcript variant X4
receptor-type tyrosine-protein phosphatase T isoform X1
receptor-type tyrosine-protein phosphatase T isoform X2
receptor-type tyrosine-protein phosphatase T isoform X3
receptor-type tyrosine-protein phosphatase T isoform X5
receptor-type tyrosine-protein phosphatase T isoform X6
receptor-type tyrosine-protein phosphatase T isoform X4
suppressor of glucose, autophagy associated 1, transcript variant X5
suppressor of glucose, autophagy associated 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
suppressor of glucose, autophagy associated 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
suppressor of glucose, autophagy associated 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
suppressor of glucose, autophagy associated 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
acyl-CoA synthetase short chain family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
acyl-CoA synthetase short chain family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
acyl-CoA synthetase short chain family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
acetyl-coenzyme A synthetase, cytoplasmic isoform X2
acetyl-coenzyme A synthetase, cytoplasmic isoform X3
acetyl-coenzyme A synthetase, cytoplasmic isoform X1
microtubule-associated protein RP/EB family member 1-like, transcript variant X5
microtubule-associated protein RP/EB family member 1-like, transcript variant X1
microtubule-associated protein RP/EB family member 1-like, transcript variant X4
microtubule-associated protein RP/EB family member 1-like, transcript variant X3
microtubule-associated protein RP/EB family member 1-like, transcript variant X2
microtubule-associated protein RP/EB family member 1-like isoform X2
microtubule-associated protein RP/EB family member 1-like isoform X1
microtubule-associated protein RP/EB family member 1-like isoform X3
DNA (cytosine-5)-methyltransferase 3B-like
nucleolar protein 4-like b, transcript variant X1
nucleolar protein 4-like b, transcript variant X2
nucleolar protein 4-like b, transcript variant X3
polycomb group protein ASXL1-like, transcript variant X2
polycomb group protein ASXL1-like, transcript variant X1
polycomb group protein ASXL1-like, transcript variant X3
polycomb group protein ASXL1-like, transcript variant X4
polycomb group protein ASXL1-like isoform X2
polycomb group protein ASXL1-like isoform X1
polycomb group protein ASXL1-like isoform X3
polycomb group protein ASXL1-like isoform X4
kinesin family member 3B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
kinesin family member 3B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
kinesin family member 3B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pleiomorphic adenoma gene-like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 228 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleiomorphic adenoma gene-like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 209 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleiomorphic adenoma gene-like 2, transcript variant X6
pleiomorphic adenoma gene-like 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 209 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
pleiomorphic adenoma gene-like 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 209 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleiomorphic adenoma gene-like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 211 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane 9 superfamily protein member 4, transcript variant X2
transmembrane 9 superfamily protein member 4, transcript variant X1
transmembrane 9 superfamily member 4 isoform X1
transmembrane 9 superfamily member 4 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
HCK proto-oncogene, Src family tyrosine kinase
CCM2 like scaffold protein, transcript variant X2
CCM2 like scaffold protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cerebral cavernous malformations 2 protein-like isoform X2
cerebral cavernous malformations 2 protein-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcription elongation factor A protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
regulator of G protein signaling 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
regulator of G protein signaling 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
regulator of G-protein signaling 19 isoform X2
regulator of G-protein signaling 19 isoform X1
protein LKAAEAR1-like, transcript variant X2
protein LKAAEAR1-like, transcript variant X1
protein LKAAEAR1-like, transcript variant X3
opiate receptor-like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
opiate receptor-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
opiate receptor-like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
opiate receptor-like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
opiate receptor-like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
opiate receptor-like 1, transcript variant X3
opiate receptor-like 1, transcript variant X7
neuropeptides B/W receptor 2b, transcript variant X4
neuropeptides B/W receptor 2b, transcript variant X3
neuropeptides B/W receptor 2b, transcript variant X2
neuropeptides B/W receptor 2b, transcript variant X1
myelin transcription factor 1-like, transcript variant X11
myelin transcription factor 1-like, transcript variant X2
myelin transcription factor 1-like, transcript variant X9
myelin transcription factor 1-like, transcript variant X10
myelin transcription factor 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
myelin transcription factor 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
myelin transcription factor 1-like, transcript variant X12
myelin transcription factor 1-like, transcript variant X1
myelin transcription factor 1-like, transcript variant X5
myelin transcription factor 1-like isoform X2
myelin transcription factor 1-like isoform X3
myelin transcription factor 1-like isoform X6
myelin transcription factor 1-like isoform X1
myelin transcription factor 1-like isoform X4
myelin transcription factor 1-like, transcript variant X7
myelin transcription factor 1-like, transcript variant X6
myelin transcription factor 1-like, transcript variant X8
myelin transcription factor 1-like isoform X5
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like, transcript variant X3
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like, transcript variant X4
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like, transcript variant X1
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like, transcript variant X2
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like isoform X1
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like isoform X2
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like isoform X3
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pancreatic progenitor cell differentiation and proliferation factor b
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
hairy/enhancer-of-split related with YRPW motif protein 1-like, transcript variant X2
hairy/enhancer-of-split related with YRPW motif protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
hairy/enhancer-of-split related with YRPW motif protein 1-like isoform X2
hairy/enhancer-of-split related with YRPW motif protein 1-like isoform X1
hairy/enhancer-of-split related with YRPW motif protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 46-like, transcript variant X2
zinc finger and BTB domain-containing protein 46-like, transcript variant X1
zinc finger and BTB domain-containing protein 46-like, transcript variant X3
zinc finger and BTB domain-containing protein 46-like isoform X1
zinc finger and BTB domain-containing protein 46-like isoform X3
zinc finger and BTB domain-containing protein 46-like isoform X2
zinc finger protein 704-like, transcript variant X2
zinc finger protein 704-like, transcript variant X3
zinc finger protein 704-like, transcript variant X1
zinc finger protein 704-like, transcript variant X4
phosphoprotein associated with glycosphingolipid-enriched microdomains 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X4
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like isoform X2
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like isoform X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4-like isoform X3
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4-like isoform X4
YTH domain-containing family protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
YTH domain-containing family protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
YTH domain-containing family protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
YTH domain-containing family protein 1-like isoform X1
YTH domain-containing family protein 1-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
basic helix-loop-helix family, member e23
class E basic helix-loop-helix protein 23
solute carrier family 17 member 9b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
solute carrier family 17 member 9b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 17 member 9b isoform X2
solute carrier family 17 member 9b isoform X1
glucose-induced degradation protein 8 homolog
dnaJ homolog subfamily C member 5, transcript variant X2
dnaJ homolog subfamily C member 5, transcript variant X1
tripartite motif-containing protein 55-like
uridine-cytidine kinase-like 1, transcript variant X1
uridine-cytidine kinase-like 1, transcript variant X2
uridine-cytidine kinase-like 1, transcript variant X3
uridine-cytidine kinase-like 1, transcript variant X4
uridine-cytidine kinase-like 1 isoform X1
uridine-cytidine kinase-like 1 isoform X2
uridine-cytidine kinase-like 1 isoform X3
uridine-cytidine kinase-like 1 isoform X4
zinc finger protein 512B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X5
zinc finger protein 512B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X3
sterile alpha motif domain containing 10b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sterile alpha motif domain containing 10b, transcript variant X2
sterile alpha motif domain containing 10b, transcript variant X1
sterile alpha motif domain-containing protein 10 isoform X2
sterile alpha motif domain-containing protein 10 isoform X1
PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC125461233, transcript variant X2
uncharacterized LOC125461233, transcript variant X1
uncharacterized protein LOC125461233 isoform X1
uncharacterized protein LOC125461233 isoform X2
ADP-ribosylation factor GTPase activating protein 1, transcript variant X1
ADP-ribosylation factor GTPase activating protein 1, transcript variant X3
ADP-ribosylation factor GTPase activating protein 1, transcript variant X4
ADP-ribosylation factor GTPase activating protein 1, transcript variant X5
ADP-ribosylation factor GTPase activating protein 1, transcript variant X6
ADP-ribosylation factor GTPase activating protein 1, transcript variant X2
ADP-ribosylation factor GTPase-activating protein 1 isoform X1
ADP-ribosylation factor GTPase-activating protein 1 isoform X2
ADP-ribosylation factor GTPase-activating protein 1 isoform X4
ADP-ribosylation factor GTPase-activating protein 1 isoform X3
ADP-ribosylation factor GTPase-activating protein 1 isoform X5
DEP domain-containing mTOR-interacting protein-like, transcript variant X5
DEP domain-containing mTOR-interacting protein-like, transcript variant X3
DEP domain-containing mTOR-interacting protein-like, transcript variant X1
DEP domain-containing mTOR-interacting protein-like, transcript variant X4
DEP domain-containing mTOR-interacting protein-like, transcript variant X8
DEP domain-containing mTOR-interacting protein-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DEP domain-containing mTOR-interacting protein-like, transcript variant X7
DEP domain-containing mTOR-interacting protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DEP domain-containing mTOR-interacting protein-like isoform X1
DEP domain-containing mTOR-interacting protein-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
prostaglandin I2 (prostacyclin) synthase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
prostaglandin I2 (prostacyclin) synthase, transcript variant X2
potassium voltage-gated channel, Shab-related subfamily, member 1, transcript variant X2
potassium voltage-gated channel, Shab-related subfamily, member 1, transcript variant X1
potassium voltage-gated channel, Shab-related subfamily, member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily B member 1
somatomedin-B and thrombospondin type-1 domain-containing protein
uncharacterized LOC125461575, transcript variant X2
uncharacterized LOC125461575, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00581
staufen double-stranded RNA binding protein 1, transcript variant X3
staufen double-stranded RNA binding protein 1, transcript variant X4
staufen double-stranded RNA binding protein 1, transcript variant X2
staufen double-stranded RNA binding protein 1, transcript variant X1
double-stranded RNA-binding protein Staufen homolog 1 isoform X3
double-stranded RNA-binding protein Staufen homolog 1 isoform X4
double-stranded RNA-binding protein Staufen homolog 1 isoform X2
double-stranded RNA-binding protein Staufen homolog 1 isoform X1
CSE1 chromosome segregation 1-like (yeast), transcript variant X1
CSE1 chromosome segregation 1-like (yeast), transcript variant X2
brefeldin A-inhibited guanine nucleotide-exchange protein 2-like, transcript variant X1
brefeldin A-inhibited guanine nucleotide-exchange protein 2-like isoform X1
brefeldin A-inhibited guanine nucleotide-exchange protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
brefeldin A-inhibited guanine nucleotide-exchange protein 2-like isoform X2
brefeldin A-inhibited guanine nucleotide-exchange protein 2-like, transcript variant X3
brefeldin A-inhibited guanine nucleotide-exchange protein 2-like isoform X3
phosphatidylinositol-3,4, 5-trisphosphate-dependent Rac exchange factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol-3,4, 5-trisphosphate-dependent Rac exchange factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphatidylinositol-3,4, 5-trisphosphate-dependent Rac exchange factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X1
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X2
extracellular sulfatase Sulf-2-like, transcript variant X3
extracellular sulfatase Sulf-2-like, transcript variant X8
extracellular sulfatase Sulf-2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
extracellular sulfatase Sulf-2-like, transcript variant X1
extracellular sulfatase Sulf-2-like, transcript variant X5
extracellular sulfatase Sulf-2-like, transcript variant X4
extracellular sulfatase Sulf-2-like, transcript variant X2
extracellular sulfatase Sulf-2-like, transcript variant X6
extracellular sulfatase Sulf-2-like isoform X1
extracellular sulfatase Sulf-2-like isoform X3
extracellular sulfatase Sulf-2-like isoform X2
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-dependent lysophosphatidylcholine symporter 1-like isoform X1
sodium-dependent lysophosphatidylcholine symporter 1-like isoform X2
uncharacterized LOC125461268, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125461268, transcript variant X2
protein FAM110B-like, transcript variant X4
protein FAM110B-like, transcript variant X5
protein FAM110B-like, transcript variant X2
protein FAM110B-like, transcript variant X3
protein FAM110B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
thyrotropin-releasing hormone receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125461237, transcript variant X2
uncharacterized LOC125461237, transcript variant X1
junctophilin-2-like, transcript variant X1
junctophilin-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ganglioside induced differentiation associated protein 1-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ganglioside-induced differentiation-associated protein 1-like 1
fat storage inducing transmembrane protein 2, transcript variant X1
fat storage inducing transmembrane protein 2, transcript variant X3
fat storage inducing transmembrane protein 2, transcript variant X4
fat storage inducing transmembrane protein 2, transcript variant X2
acyl-coenzyme A diphosphatase FITM2 isoform X1
acyl-coenzyme A diphosphatase FITM2 isoform X3
acyl-coenzyme A diphosphatase FITM2 isoform X2
peptidase inhibitor 15-like, transcript variant X1
peptidase inhibitor 15-like, transcript variant X2
hepatocyte nuclear factor 4, alpha, transcript variant X2
hepatocyte nuclear factor 4-alpha isoform X2
hepatocyte nuclear factor 4, alpha, transcript variant X4
uncharacterized LOC125461342, transcript variant X2
uncharacterized LOC125461342, transcript variant X1
hepatocyte nuclear factor 4, alpha, transcript variant X6
hepatocyte nuclear factor 4, alpha, transcript variant X1
hepatocyte nuclear factor 4, alpha, transcript variant X5
hepatocyte nuclear factor 4-alpha isoform X1
hepatocyte nuclear factor 4, alpha, transcript variant X3
hepatocyte nuclear factor 4-alpha isoform X3
tocopherol (alpha) transfer protein-like
adenosine deaminase, transcript variant X3
adenosine deaminase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
adenosine deaminase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger, CCCH-type with G patch domain
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
zinc finger CCCH-type with G patch domain-containing protein
ADP-ribosylation factor related protein 1, transcript variant X1
ADP-ribosylation factor related protein 1, transcript variant X2
ADP-ribosylation factor-related protein 1 isoform X2
ADP-ribosylation factor-related protein 1 isoform X1
tumor necrosis factor receptor superfamily member 6B-like
regulator of telomere elongation helicase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
regulator of telomere elongation helicase 1, transcript variant X3
regulator of telomere elongation helicase 1, transcript variant X1
regulator of telomere elongation helicase 1 isoform X1
regulator of telomere elongation helicase 1, transcript variant X4
regulator of telomere elongation helicase 1 isoform X2
glucocorticoid modulatory element binding protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
glucocorticoid modulatory element binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glucocorticoid modulatory element binding protein 2, transcript variant X5
glucocorticoid modulatory element-binding protein 2 isoform X2
glucocorticoid modulatory element binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glucocorticoid modulatory element-binding protein 2 isoform X1
glucocorticoid modulatory element binding protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glucocorticoid modulatory element-binding protein 2 isoform X3
helicase with zinc finger 2a, transcript variant X2
helicase with zinc finger 2a, transcript variant X1
helicase with zinc finger domain 2 isoform X1
helicase with zinc finger 2a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
helicase with zinc finger domain 2 isoform X2
serine/threonine kinase 35, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine kinase 35, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
fibronectin type III domain-containing protein 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
3'(2'), 5'-bisphosphate nucleotidase 2, transcript variant X2
3'(2'), 5'-bisphosphate nucleotidase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
cadherin-like protein 26, transcript variant X3
cadherin-like protein 26, transcript variant X2
cadherin-like protein 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 9 member 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
solute carrier family 9 member 8, transcript variant X2
solute carrier family 9 member 8, transcript variant X3
solute carrier family 9 member 8, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
spermatogenesis associated 2, transcript variant X4
spermatogenesis associated 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
spermatogenesis associated 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
spermatogenesis associated 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ring finger protein 114, transcript variant X1
ring finger protein 114, transcript variant X2
ubiquitin-conjugating enzyme E2 variant 1-like, transcript variant X4
ubiquitin-conjugating enzyme E2 variant 1-like, transcript variant X1
ubiquitin-conjugating enzyme E2 variant 1-like, transcript variant X3
ubiquitin-conjugating enzyme E2 variant 1-like, transcript variant X2
ubiquitin-conjugating enzyme E2 variant 1-like isoform X3
ubiquitin-conjugating enzyme E2 variant 1-like isoform X1
ubiquitin-conjugating enzyme E2 variant 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
CCAAT/enhancer-binding protein beta-like
uncharacterized LOC125461536, transcript variant X1
uncharacterized LOC125461536, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
tyrosine-protein phosphatase non-receptor type 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
partitioning defective 6 homolog beta-like
breast carcinoma-amplified sequence 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
activity-dependent neuroprotector homeobox b, transcript variant X3
activity-dependent neuroprotector homeobox b, transcript variant X1
activity-dependent neuroprotector homeobox b, transcript variant X2
activity-dependent neuroprotector homeobox b
dolichyl-phosphate mannosyltransferase subunit 1, catalytic, transcript variant X1
dolichyl-phosphate mannosyltransferase subunit 1, catalytic, transcript variant X2
dolichol-phosphate mannosyltransferase subunit 1 isoform X1
dolichol-phosphate mannosyltransferase subunit 1 isoform X2
potassium voltage-gated channel, subfamily G, member 1, transcript variant X1
potassium voltage-gated channel, subfamily G, member 1, transcript variant X2
potassium voltage-gated channel subfamily G member 1
uncharacterized LOC125461644, transcript variant X4
uncharacterized LOC125461644, transcript variant X3
uncharacterized LOC125461644, transcript variant X1
uncharacterized LOC125461644, transcript variant X2
nuclear factor of activated T cells 2a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear factor of activated T cells 2a, transcript variant X4
nuclear factor of activated T cells 2a, transcript variant X2
nuclear factor of activated T cells 2a, transcript variant X1
nuclear factor of activated T-cells, cytoplasmic 2 isoform X2
nuclear factor of activated T-cells, cytoplasmic 2 isoform X1
nuclear factor of activated T-cells, cytoplasmic 2 isoform X3
probable phospholipid-transporting ATPase IIA, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
probable phospholipid-transporting ATPase IIA, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
probable phospholipid-transporting ATPase IIA isoform X2
probable phospholipid-transporting ATPase IIA isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
brain enriched myelin associated protein 1, transcript variant X2
brain enriched myelin associated protein 1, transcript variant X1
brain enriched myelin associated protein 1, transcript variant X6
brain enriched myelin associated protein 1, transcript variant X3
brain enriched myelin associated protein 1, transcript variant X4
breast carcinoma-amplified sequence 1 isoform X1
breast carcinoma-amplified sequence 1 isoform X3
breast carcinoma-amplified sequence 1 isoform X2
breast carcinoma-amplified sequence 1 isoform X5
brain enriched myelin associated protein 1, transcript variant X5
brain enriched myelin associated protein 1, transcript variant X7
breast carcinoma-amplified sequence 1 isoform X4
breast carcinoma-amplified sequence 1 isoform X6
zinc finger protein 217, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger protein 217, transcript variant X3
zinc finger protein 217, transcript variant X1
zinc finger protein 217, transcript variant X2
prefoldin subunit 4, transcript variant X1
prefoldin subunit 4, transcript variant X2
prefoldin subunit 4, transcript variant X3
prefoldin subunit 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
formin-like protein 13, transcript variant X2
formin-like protein 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 210 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger, NFX1-type containing 1, transcript variant X5
zinc finger, NFX1-type containing 1, transcript variant X2
zinc finger, NFX1-type containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
NFX1-type zinc finger-containing protein 1 isoform X2
zinc finger, NFX1-type containing 1, transcript variant X6
zinc finger, NFX1-type containing 1, transcript variant X4
zinc finger, NFX1-type containing 1, transcript variant X1
NFX1-type zinc finger-containing protein 1 isoform X1
NFX1-type zinc finger-containing protein 1 isoform X3
cyclin D-type binding-protein 1, transcript variant X1
cyclin D-type binding-protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
cyclin-D1-binding protein 1 homolog isoform X1
cyclin-D1-binding protein 1 homolog isoform X2
protein-glutamine gamma-glutamyltransferase 2-like, transcript variant X2
protein-glutamine gamma-glutamyltransferase 2-like, transcript variant X1
protein-glutamine gamma-glutamyltransferase 2-like isoform X1
protein-glutamine gamma-glutamyltransferase 2-like isoform X2
protein-glutamine gamma-glutamyltransferase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X1
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X2
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X2
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X1
TELO2 interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TELO2 interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
TELO2 interacting protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TELO2 interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
V-set and transmembrane domain-containing protein 2-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
pleckstrin homology domain-containing family G member 4B, transcript variant X2
pleckstrin homology domain-containing family G member 4B, transcript variant X1
pleckstrin homology domain-containing family G member 4B isoform X2
pleckstrin homology domain-containing family G member 4B isoform X1
bactericidal permeability-increasing protein-like
CDK5 regulatory subunit associated protein 1
CDK5 regulatory subunit-associated protein 1
BPI fold containing family C, like, transcript variant X1
BPI fold containing family C, like, transcript variant X2
bactericidal permeability-increasing protein isoform X1
bactericidal permeability-increasing protein isoform X2
iroquois-class homeodomain protein irx-1-A-like
ankyrin repeat domain-containing protein SOWAHA, transcript variant X4
ankyrin repeat domain-containing protein SOWAHA, transcript variant X3
ankyrin repeat domain-containing protein SOWAHA, transcript variant X2
ankyrin repeat domain-containing protein SOWAHA, transcript variant X1
ankyrin repeat domain-containing protein SOWAHA isoform X3
ankyrin repeat domain-containing protein SOWAHA isoform X2
ankyrin repeat domain-containing protein SOWAHA isoform X1
zinc finger protein 335, transcript variant X2
zinc finger protein 335, transcript variant X4
zinc finger protein 335, transcript variant X1
zinc finger protein 335, transcript variant X3
zinc finger protein 335, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 12 member 5-like, transcript variant X1
solute carrier family 12 member 5-like isoform X1
solute carrier family 12 member 5-like, transcript variant X2
solute carrier family 12 member 5-like isoform X2
solute carrier family 12 member 5-like, transcript variant X3
solute carrier family 12 member 5-like isoform X3
nuclear receptor coactivator 5, transcript variant X1
nuclear receptor coactivator 5, transcript variant X4
nuclear receptor coactivator 5, transcript variant X3
nuclear receptor coactivator 5, transcript variant X2
nuclear receptor coactivator 5 isoform X2
nuclear receptor coactivator 5 isoform X1
nuclear receptor coactivator 5 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 24% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 40% coverage of the annotated genomic feature by RNAseq alignments
troponin C, skeletal muscle-like, transcript variant X2
troponin C, skeletal muscle-like, transcript variant X1
uncharacterized protein LOC125461311 isoform X2
troponin C, skeletal muscle-like isoform X1
uncharacterized LOC125461312, transcript variant X2
uncharacterized LOC125461312, transcript variant X1
neuralized E3 ubiquitin protein ligase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sorting nexin family member 21, transcript variant X1
sorting nexin family member 21, transcript variant X2
sorting nexin family member 21, transcript variant X3
uncharacterized LOC125461281, transcript variant X1
uncharacterized LOC125461281, transcript variant X2
troponin C, skeletal muscle-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cleavage stimulation factor, 3' pre-RNA, subunit 1
enhancer of filamentation 1-like, transcript variant X2
enhancer of filamentation 1-like isoform X2
enhancer of filamentation 1-like, transcript variant X1
cas scaffolding protein family member 4-like isoform X1
AP-1 complex subunit gamma-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
AP-1 complex subunit gamma-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
AP-1 complex subunit gamma-1-like isoform X2
AP-1 complex subunit gamma-1-like isoform X1
tumor necrosis factor receptor superfamily member 5-like
tumor necrosis factor receptor superfamily member 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5-like, transcript variant X1
tumor necrosis factor receptor superfamily member 5-like isoform X1
tumor necrosis factor receptor superfamily member 5-like isoform X4
tumor necrosis factor receptor superfamily member 5-like isoform X2
tumor necrosis factor receptor superfamily member 5-like isoform X3
acyl-coenzyme A diphosphatase NUDT19-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
acyl-coenzyme A diphosphatase NUDT19-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
acyl-coenzyme A diphosphatase NUDT19-like
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27
probable ATP-dependent RNA helicase DDX27
small nuclear ribonucleoprotein polypeptides B and B1
small nuclear ribonucleoprotein-associated proteins B and B'
engulfment and cell motility protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
engulfment and cell motility protein 2, transcript variant X1
engulfment and cell motility protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
engulfment and cell motility protein 2, transcript variant X5
engulfment and cell motility protein 2, transcript variant X4
engulfment and cell motility protein 2 isoform X2
engulfment and cell motility protein 2 isoform X1
engulfment and cell motility protein 2 isoform X3
solute carrier family 35 member C2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 35 member C2, transcript variant X2
solute carrier family 35 member C2, transcript variant X1
solute carrier family 35 member C2 isoform X1
solute carrier family 35 member C2 isoform X2
solute carrier family 35 member C2 isoform X3
GNAS complex locus, transcript variant X1
GNAS complex locus, transcript variant X2
guanine nucleotide-binding protein G(s) subunit alpha isoform X1
guanine nucleotide-binding protein G(s) subunit alpha isoform X2
negative elongation factor complex member C/D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
negative elongation factor complex member C/D, transcript variant X3
negative elongation factor C/D isoform X1
negative elongation factor C/D isoform X3
negative elongation factor complex member C/D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
negative elongation factor C/D isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein TMEPAI-like, transcript variant X4
protein TMEPAI-like, transcript variant X2
protein TMEPAI-like, transcript variant X1
protein TMEPAI-like, transcript variant X3
uncharacterized LOC125461374, transcript variant X1
uncharacterized LOC125461374, transcript variant X2
uncharacterized protein LOC125461374 isoform X1
uncharacterized protein LOC125461374 isoform X2
tubulin tyrosine ligase-like family, member 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
myosin light chain kinase 2, skeletal/cardiac muscle-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WAP four-disulfide core domain protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
regulator of G-protein signaling 9-binding protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
deoxynucleotidyltransferase terminal-interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
deoxynucleotidyltransferase terminal-interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
deoxynucleotidyltransferase terminal-interacting protein 1 isoform X2
deoxynucleotidyltransferase terminal-interacting protein 1 isoform X1
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phosphorylated CTD interacting factor 1, transcript variant X1
phosphorylated CTD interacting factor 1, transcript variant X2
phosphorylated CTD interacting factor 1, transcript variant X3
phosphorylated CTD interacting factor 1, transcript variant X4
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase
phospholipid transfer protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phospholipid transfer protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
phospholipid transfer protein isoform X1
phospholipid transfer protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phospholipid transfer protein isoform X2
cytochrome c oxidase subunit 4 isoform 1, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma), transcript variant X2
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcription factor AP-2 gamma isoform X2
transcription factor AP-2 gamma isoform X1
replication termination factor 2, transcript variant X2
replication termination factor 2, transcript variant X1
replication termination factor 2 isoform X2
replication termination factor 2 isoform X1
glucosaminyl (N-acetyl) transferase family member 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7
SPO11 initiator of meiotic double stranded breaks
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125461251, transcript variant X2
uncharacterized LOC125461251, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like, transcript variant X1
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like, transcript variant X2
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ATP synthase subunit epsilon, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 521 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis, class T, transcript variant X1
phosphatidylinositol glycan anchor biosynthesis, class T, transcript variant X2
GPI transamidase component PIG-T isoform X1
GPI transamidase component PIG-T isoform X2
piezo-type mechanosensitive ion channel component 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
VAMP (vesicle-associated membrane protein)-associated protein B and C, transcript variant X2
VAMP (vesicle-associated membrane protein)-associated protein B and C, transcript variant X1
vesicle-associated membrane protein-associated protein B/C isoform X2
vesicle-associated membrane protein-associated protein B/C isoform X1
RAB22A, member RAS oncogene family, transcript variant X2
RAB22A, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein phosphatase 4, regulatory subunit 1-like
serine/threonine-protein phosphatase 4 regulatory subunit 1
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like, transcript variant X3
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like isoform X2
ankyrin repeat domain-containing protein 60-like
uncharacterized protein C20orf85-like, transcript variant X2
uncharacterized protein C20orf85-like, transcript variant X1
uncharacterized protein C20orf85-like isoform X2
uncharacterized protein C20orf85-like isoform X1
androgen dependent TFPI regulating protein 1, transcript variant X4
androgen dependent TFPI regulating protein 1, transcript variant X2
androgen dependent TFPI regulating protein 1, transcript variant X1
androgen dependent TFPI regulating protein 1, transcript variant X3
androgen dependent TFPI regulating protein 1, transcript variant X5
androgen dependent TFPI regulating protein 1, transcript variant X6
androgen dependent TFPI regulating protein 1 isoform X4
androgen dependent TFPI regulating protein 1 isoform X3
androgen dependent TFPI regulating protein 1 isoform X2
androgen dependent TFPI regulating protein 1 isoform X1
androgen dependent TFPI regulating protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X3
NACHT, LRR and PYD domains-containing protein 3-like isoform X1
NACHT, LRR and PYD domains-containing protein 3-like isoform X2
NACHT, LRR and PYD domains-containing protein 3-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54% coverage of the annotated genomic feature by RNAseq alignments
probable G-protein coupled receptor 139, transcript variant X2
probable G-protein coupled receptor 139, transcript variant X1
probable G-protein coupled receptor 139 isoform X1
probable G-protein coupled receptor 139 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns